Our findings establish a signaling pathway, going from JAK2/STAT3 to C/EBPβ to δ-secretase, delineating the molecular mechanisms of how BDNF/TrkB deficiency contributes to AD pathogenesis. This evidence concerns the gene BDNF and Alzheimer disease.